MYP_026276
Basic Information
IPB05(SARS-CoV-2-S (1179-1205))
Antimicrobial
Antiviral
Antiviral Anti-Coronavirus Anti-SARS-CoV
Antiviral Anti-Coronavirus Anti-SARS-CoV-2
Antiviral Anti-HIV
Antiviral Antiviral mechanism Viral entry inhibition Entry inhibitor
Antiviral Antiviral mechanism Viral fusion inhibition
Antiviral Antiviral mechanism Viral fusion inhibition Fusion inhibitor
Membrane / Ion-channel modulation Sodium channel modulation Sodium channel inhibitor
Standard
27 amino acids
C135H232N38O46
Standard
Sequence
IQKEIDRLNEVAKNLNESLIDLQELGK
Physicochemical Analysis
3123.51 Da
4.66
-2.23
-2.44
-0.0826
-0.64
0.69
-0.16
37.17
130.00
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1419.36
-13.11
46.0
44.0
115.0
219.0
0.0
31.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0389438 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
Chol
Bio-Activity Profile
Antimicrobial Anti-SARS-CoV-2
SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC>25 μM)
RECORD: Rec_0408012 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HIV Fusion inhibition
HIV-luc/SARS pseudotyped virus | 293T cells
1.19 μM
EC50
Mammalian: 20 h; Yeast: 30 min; E. coli: >10 h
FIRST PREV 1 ... 3 4 5
Showing 2 records on this page · Page 5 of 5